SCHEMBL7201875

SCHEMBL7201875

CCCc1nn(C)c2c(Cl)nc(CCC(=O)OC)nc12.CCCc1nn(C)c2c(NCc3ccccc3)nc(CCC(=O)OC)nc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 4/20 0.38
PDE3B Q13370 3/20 0.38
PDE3A Q14432 3/20 0.38
PDE4A P27815 2/20 0.38
PDE4B Q07343 2/20 0.38
PDE4C Q08493 2/20 0.38
PDE4D Q08499 2/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
KDM4E B2RXH2 1/20 0.36
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
PPARG P37231 1/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 2/20 0.35
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35
HPGD P15428 1/20 0.35
PDE1A P54750 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707575 0.95 PDE5A (0.41) PDE5APDE3BPDE3APDE4APDE4B
SCHEMBL6707012 0.89 PDE4A (0.43) PDE5APDE3BPDE3APDE4APDE4B
SCHEMBL6708871 0.89 PDE4A (0.42) PDE5APDE3BPDE3APDE4APDE4B
SCHEMBL6710419 0.86 PDE5A (0.43) PDE5APDE3BPDE3APDE4APDE4B
SCHEMBL6709011 0.85 MTOR (0.39) PDE5ANPC1RAB9AKDM4EMEN1
SCHEMBL6706970 0.83 PDE11A (0.43) PDE5A
SCHEMBL6708992 0.83 PDE4A (0.45) PDE5APDE3BPDE3APDE4APDE4B
SCHEMBL6710407 0.82 PDE4A (0.44) PDE5APDE3BPDE3APDE4APDE4B
SCHEMBL6707578 0.79 MTOR (0.38) PDE5ANPC1RAB9AKDM4EMEN1
SCHEMBL6708662 0.79 MAPT (0.45) PDE5ARAB9AKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1343506-A1 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO 4,3-D]PYRIMIDINES AND ANTITHROMBOTIC AGENTS, CALCIUM-ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES MERCK PATENT GmbH (DE) 2003-09-17 EP disclosed
WO-2002049651-A1 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO[4,3-D]PYRIMIDINES AND ANTITHROMBOTIC AGENTS, CALCIUM-ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES MERCK PATENT GMBH (DE) 2002-06-27 WO disclosed